The Initial Public Offering (IPO) landscape for the HealthTech and MedTech sectors is projected to undergo a significant recovery in 2026. Following a period of volatility and retrenchment between 2022 and 2024, the confluence of stabilising macroeconomic conditions, investor appetite for disruptive technology and a substantial backlog of highly mature companies suggests that 2026 will be the most active year for public offerings since the market peaks of 2021.

Nelson Advisors will be speaking, presenting and chairing a number of panels at HealthTech conferences and events in October, November and December 2025. Please feel free to come and meet us in person or to book a meeting with us online please visit https://scheduler.zoom.us/nelson-advisors/meeting

Major developments in European HealthTech this week have been dominated by major funding rounds in biotech, significant regulatory alignment and continued investment in digital health. The last week in European MedTech has been dominated by regulatory and funding activities, as well as continued momentum in digital health and surgical innovation.

Nelson Advisors Partner Lloyd Price has been invited to join the "Health Data Under Attack: Emerging Vulnerabilities in Healthcare” panel at Health Tech Forward 2025 Conference in Barcelona.

The sustained market leading position of Epic MyChart is not attributable solely to superior user experience or functionality, but rather represents a direct, structural consequence of Epic Systems’ foundational dominance in the enterprise Electronic Health Record (EHR) market, particularly among large Integrated Delivery Networks (IDNs). This EHR control provides an insurmountable competitive barrier, securing MyChart’s deployment across vast healthcare ecosystems.

This report provides strategic foresight into five dominant mega trends shaping the European HealthTech and MedTech landscape for 2026. The year marks a critical nexus where groundbreaking technological acceleration meets definitive regulatory enforcement, primarily through the EU AI Act and the European Health Data Space (EHDS) regulation.

The Ambient Clinical Intelligence (ACI) sector, powered by Ambient Voice Technology (AVT), has transitioned rapidly from a nascent concept to a primary focus for large-scale venture capital deployment within enterprise healthcare. The underlying technology, rooted in Generative AI (GenAI), is fundamentally disrupting clinical workflows, promising to alleviate the persistent crisis of physician burnout driven by administrative documentation burden.

Nelson Advisors thought leadership has been referenced in the Forbes article '5 High-Growth Business Models Set To Thrive In The Coming Decade' outlining five business models that are primed for success in the coming years.

The intersection between defense innovation and medical technology (MedTech) represents a fundamental structural shift, moving beyond simple technological spillovers to establish a mutually reinforcing economic and R&D ecosystem. Military Research and Development (R&D) functions as a highly accelerated, high-stakes validation engine, forcing the creation of exceptionally robust, autonomous, and efficient medical capabilities required for assured care in austere and contested

The global sleep technology sector is poised for a significant strategic inflection point by 2026, driven by the convergence of advanced consumer hardware and clinically validated digital therapeutics. Market forecasts confirm a robust growth trajectory, positioning the sector to move decisively beyond generalised wellness tracking into the regulated realm of personalised health intervention. The global Sleep Tech Devices market is projected to reach approximately USD $30.74

The global financial system is currently operating under a pervasive and quantifiable risk of a sharp market correction, a hazard explicitly documented by the Bank of England's (BoE) Financial Policy Committee (FPC) in its October 2025 update. The core driver of this instability is the hyper-concentration and seemingly limitless valuation of assets tethered to Artificial Intelligence (AI) technology. The FPC has raised a clear warning regarding the growing risk that tech stoc

Nelson Advisors is positioned as a highly specialised M&A advisory firm with an exclusive dedication to the dynamic European healthcare technology (HealthTech) sector, with advisory reach across the UK and North America. This focused dedication forms the bedrock of their value proposition, enabling a nuanced understanding of the technological advancements and market dynamics that are critical for successful transactions within this complex industry.

Nelson Advisors has been invited to join the 'Startups and Corporates: How to Build Meaningful Partnerships in MedTech' panel at MedTech Europe 2025. Nelson Advisors Partner Lloyd Price will join fellow panellists including..

The Healthtech industry operates at the critical confluence of rapid technological velocity and necessary regulatory gravity. This dynamic tension, exemplified by the swift advancement of digital innovation (e.g., AI/ML) encountering historically complex and risk-averse regulatory frameworks (such as HIPAA and FDA oversight), demands an organisational philosophy built not on rigidity, but on adaptive strength. The Bamboo Mindset, defined by its core pillars of Flexibility, Re

The major stories in the world of European MedTech this week are dominated by regulatory activity under the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), a significant European Commission "Call for Evidence" for future reforms, and fresh funding for companies focused on connected and remote monitoring devices.